Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505)†

Add time:07/20/2019    Source:sciencedirect.com

BackgroundWhile producing good-quality analgesia, µ-opioid (MOP) receptor activation produces a number of side-effects including tolerance. Simultaneous blockade of δ-opioid (DOP) receptors has been shown to reduce tolerance to morphine. Here, we characterize a prototype bifunctional opioid H-Dmt-Tic-Gly-NH-Bzl (UFP-505).

We also recommend Trading Suppliers and Manufacturers of H-HIS(BZL)-OH (cas 16832-24-9). Pls Click Website Link as below: cas 16832-24-9 suppliers

Prev:Four new amide derivatives of pyridinecarboxylic acids. Synthesis, structure and spectroscopic characterization
Next:Metabolic and mutagenicity studies on DDT and 15 derivatives. Detection of 1.1-bis(p-chlorophenyl)-2,2-dichloroethane and 1.1-bis(p-chlorophenyl)-2,2,2-trichloroethyl acetate (kelthane acetate) as mutagens in Salmonella typhimurium and of 1.1-bis(p-chlorophenyl) ethylene oxide, a likely metabolite, as an alkylating agent)